Nov. 24 at 4:08 AM
$TTRX Turn Therapeutics earns national recognition as one of the “Five Novel Mechanisms Reshaping Atopic Dermatitis Treatment.” Learn how the GX-03 IL-36–targeting technology could disrupt the
$20B eczema market ahead of 2026 topline data. https://biotechhealthx.com/biotech-news/turn-therapeutics-ttrx-named-top-innovator-in-atopic-dermatitis-with-gx-03-breakthrough/